Psychosis in Parkinson's disease: how should we treat it?

Expert Rev Neurother. 2006 Sep;6(9):1243-6. doi: 10.1586/14737175.6.9.1243.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antiparkinson Agents / adverse effects*
  • Antiparkinson Agents / therapeutic use
  • Antipsychotic Agents / administration & dosage*
  • Humans
  • Parkinson Disease / complications*
  • Parkinson Disease / drug therapy
  • Practice Guidelines as Topic
  • Practice Patterns, Physicians' / trends
  • Psychotic Disorders / etiology*
  • Psychotic Disorders / therapy*

Substances

  • Antiparkinson Agents
  • Antipsychotic Agents